In a report released today, Jason Gabelman from TD Cowen maintained a Hold rating on Calumet Specialty Products (CLMT – Research Report), with a price target of $14.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jason Gabelman has given his Hold rating due to a combination of factors impacting Calumet Specialty Products. One significant reason is the unexpected increase in net debt by $190 million, despite the earlier-than-expected closing of the Royal Purple asset sale. This increase was influenced by factors such as a $40 million impact from working capital and $30 million higher interest expenses.
Additionally, while there are potential avenues for deleveraging, such as further asset sales and monetization of PTC credits, the earnings outlook for MRL remains uncertain in the near-to-medium term. The company is also tightening its spending on the MaxSAF expansion, which indicates a cautious approach to capital expenditures. These elements combined suggest a balanced view, leading to the Hold rating.